EcoDrugPlus

Interleukin 5

Ensembl ID : ENSCHYG00000001775
Gene Symbol: IL5
1 Cross references
91 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSCHYG00000014515
Gene Symbol: IDH2
1 Cross references
261 Possible Orthologues:

Kallikrein B1

Ensembl ID : ENSCHYG00000013854
Gene Symbol: KLKB1
1 Cross references
209 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSCHYG00000002009
Gene Symbol: KEAP1
1 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSCHYG00000014384
Gene Symbol: KDR
1 Cross references
199 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSCHYG00000006424
Gene Symbol: KIF11
1 Cross references
203 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSCHYG00000023791
Gene Symbol: KIF5B
1 Cross references
288 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSCHYG00000017296
Gene Symbol: LTA4H
1 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSCHYG00000007584
Gene Symbol: LTB4R
1 Cross references
141 Possible Orthologues:

Leukotriene B4 Receptor 2

Ensembl ID : ENSCHYG00000007593
Gene Symbol: LTB4R2
1 Cross references
238 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSCHYG00000007485
Gene Symbol: KDM1A
1 Cross references
214 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSCHYG00000025533
Gene Symbol: LOXL2
1 Cross references
288 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).